Contact
Please use this form to send email to PR contact of this press release:
Concarlo Therapeutics Presents Novel Therapeutic Approach for ER+ Metastatic Breast Cancer Targeting the CDK Pathway
TO:
Ariel Kramer
Concarlo Therapeutics